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ABSTRACT 
Background: Serological studies indicate that evidence of coeliac disease (CD) exists in about 1% 
of all children, but we lack estimates of current diagnostic patterns among children and how they 
vary by socioeconomic group. 
Methods:  We identified all children aged 0-18 years between 1993 and 2012 who were registered 
with general practices across the United Kingdom (UK) that contribute to a large population-based 
general practice database. The incidence of CD was evaluated in each quintile of the Townsend 
Index of Deprivation and stratified by age, sex, country and calendar year. 
Results: Among 2,063,421 children we identified 1,247 CD diagnoses, corresponding to an overall 
CD incidence of 11.9 per 100,000 person-years, which was similar across the UK countries and 
higher in girls than in boys. We found a gradient of CD diagnosis across socioeconomic groups, 
with the rate of diagnosis being 80% higher in children from the least deprived areas than in those 
from the most deprived areas (Incident Rate Ratio 1.80, 95%CI 1.45-2.22). This pattern held for 
both boys and girls and across all ages. Across all four countries of the UK, we found similar 
associations between CD and socioeconomic status. Whilst CD incidence up to age 2 remained 
stable over the study period, diagnoses at older ages have almost tripled over the past 20 years. 
Conclusion: Children living in less socioeconomically deprived areas in the UK are more likely to 
be diagnosed with CD. Increased implementation of diagnostic guidelines could result in better case 
identification in more deprived areas. 
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INTRODUCTION  
Screening studies among children in the United States of America and Western Europe report a 
sero-prevalence of coeliac disease (CD) of around 1%.[1-6]  However, over the last two decades, 
several studies have reported an increased incidence of biopsy-detected CD in children,[7] the 
reason for which is unclear. One explanation for the increase is that it represents improved 
ascertainment due to heightened clinical awareness underpinned by  improved accuracy and 
availability of diagnostic tests [8] and/or to screening programs in people with associated 
diseases.[9]  If this increase in clinically diagnosed paediatric CD does only represent improved 
ascertainment then one might expect it to be more marked in higher socioeconomic groups. This is 
because children of higher socioeconomic status are more likely to seek health care,[10] and 
therefore oppoUWXQLWLHVIRULQYHVWLJDWLRQLQVRFDOOHG³DWULVN´JURXSVZRXOGEHH[SHFWHGWRRFFXU
more frequently among them which may lead to more frequent testing for CD.[11] The few studies 
that have investigated a possible socioeconomic gradient in CD have reported conflicting 
results.[12-21] In view of this and the lack of population-based studies, assessing patterns of clinical 
diagnosis of CD among children in the United Kingdom (UK), we examined the incidence of CD 
up to 18 years of age and its variation by socioeconomic group, taking into account age, sex, 
calendar period and country within the UK. 
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METHODS 
Data were obtained from The Health Improvement Network (THIN), a nationally representative UK 
database of primary care records, containing medical diagnoses, events, and drug prescriptions.[22] 
Our cohort was all children aged 0-18 years registered with a THIN general practice (GP) at any 
time from 1 January 1993 to 31 December 2012. We identified all incident diagnoses of CD based 
RQWKHSUHVHQFHRIRQHRUPRUHRIWKHIROORZLQJ5HDGFRGHVUHFRUGHGLQFKLOGUHQ¶V*3UHFRUGV
J690.00-Coeliac disease, J690.13-Gluten enteropathy, J690z00-Coeliac disease NOS. For patients 
with more than one CD code, the earliest was considered as the date of disease diagnosis. Children 
with CD recorded before their entry date were considered to have prevalent disease and were thus 
excluded.   
The incidence of CD per 100,000 person-years was calculated by dividing the number of children 
with CD by the total follow-up time contributed to the study period by all children. Incidence was 
stratified by age, sex, country of residence (England, Scotland, Wales and Northern Ireland), 
calendar year (grouped as quinquennia) and household socioeconomic quintile, measured by the 
Townsend Index.[23] Townsend index measures area-level (approximately 50 households) 
deprivation based on local unemployment, car ownership, overcrowding and home ownership from 
the 2001 Census; use of quintiles maintains anonymity. 
Poisson regression was used to calculate unadjusted Incidence Rate Ratios (IRRs) for CD by all 
factors and potential interactions were assessed using the Likelihood Ratio Test (LRT). Age was 
grouped into three age bands (0-2, 3-9, 10-18), similar to that in previous demographic studies of 
CD.[17, 24, 25] Although prevalent CD cases had been excluded, children with a first diagnosis 
recorded soon after their GP registration may have had prevalent disease upon study entry 
(diagnosed before but recorded near the time of GP registration). Therefore, we conducted a 
sensitivity analysis excluding patients whose first CD diagnosis or gluten-free product prescription 
was recorded within six months of initial registration, unless they were diagnosed at younger than 
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age 2 years. This method of excluding potentially prevalent cases was based on Lewis et al¶V[26] 
but tailored to children, since diagnoses very early in life are likely to be incident regardless of 
proximity to registration. We conducted a second sensitivity analysis to exclude potential CD 
overestimation, using a restricted CD definition where cases had to have at least one gluten-free 
product prescription associated with their CD diagnosis. In the UK, children with CD are eligible to 
receive free prescriptions from their GP to purchase gluten-free foods, funded by the public 
National Health Service. Whilst CD patients are not required to obtain these prescriptions, they 
would not be received unless a definitive CD diagnosis was made. Analyses were performed using 
Stata 12. This study was approved by the THIN Scientific Review Committee (protocol 13-075). 
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RESULTS 
There were 2,063,421 children in our study population, contributing a total of 10,508,374 person-
years. Their median follow-up was 3.8 years (interquartile range 1.5-7.9) and 1,247 children were 
diagnosed with CD, corresponding to an overall incidence rate of 11.9 per 100,000 person-years.  
 
Socio-demographic distribution of CD diagnoses 
Table 1 shows variations in the rate of CD diagnosis by sex, age, country, calendar period and 
socioeconomic deprivation. The rate of CD in girls was 53% higher (IRR 1.53, 95% CI 1.37-1.72) 
than in boys. Incidence varied by age with the lowest CD in children younger than 1 after which it 
increased to 18.7 and 17.9 per 100,000 person-years at ages 1 and 2 years, respectively. Incidence 
then decreased, ranging between 8.4 and 15.1 per 100,000 person-years between ages 3-18 years. 
We did not find significant geographic variation across the UK, with a similar CD incidence 
observed in the four countries. Across the 20-year period studied, there was a clear increase with a 
CD diagnosis rate in the last 5 years (2008-2012) that was 75% higher than in 1993-1997 (IRR 
1.75, 95% CI 1.31-2.34).  
Table 2 shows how the incidence of CD varied by sex, age and country over the study period. There 
was a 39% increase in boys (IRR 1.39 95% CI 0.92-2.10) and a 2-fold increase in girls (IRR 2.09, 
95% CI 1.39-3.13). However, there was no statistically significant interaction between sex and 
calendar period (LRT p-value for interaction=0.4). Conversely, across the three age groups studied, 
there was a statistically significant interaction with calendar period (LRT p<0.001). Children aged 
0-2 years had a roughly constant CD incidence over time whereas children aged 3-18 years had 3-
fold increase from 1993-1997 to 2008-2012 periods. CD incidence increased over time in England 
and Scotland, while we did not observe a statistically significantly increase in Wales and Northern 
Ireland.  
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Table 1. Incidence of Coeliac Disease  (N=2,063,421) 
  
Number of coeliac 
disease cases Person-years 
Rate per 100,000 
person-years (95% 
confidence interval)  
Unadjusted 
Incidence Rate 
Ratios (95% 
confidence 
interval) 
Overall 1,247 10,508,374 11.9 (11.2-12.5)  
Sex 
   
 
Male 514 5,448,627 9.4 (8.6-10.3) 1 
Female 733 5,059,747 14.5 (13.5-15.6) 1.53 (1.37.1.72) 
Age (years) 
   
 
        <1 24 599,728 4.0 (2.7-6.0)  
        1 125 668,994 18.7 (15.7-22.2)  
        2 119 662,631 17.9 (15.0-21.5)  
        3 91 653,575 13.9 (11.3-17.1)  
        4 97 643,093 15.1 (12.4-18.4)  
        5 67 629,754 10.6 (8.4-13.5)  
        6 81 618,239 13.1 (10.5-16.3)  
        7 74 608,210 12.1 (9.7-15.3)  
        8 66 597,770 11 (8.7-14.0)  
        9 64 587,151 10.9 (8.5-13.9)  
       10 62 576,655 10.7 (8.4-13.8)  
       11 55 566,426 9.7  (7.4-12.6)  
       12 56 554,291 10.1 (7.7-13.1)  
       13 58 539,042 10.7 (8.3-13.9)  
       14 65 521,484 12.4 (9.7-15.9)  
       15 43 507,872 8.4 (6.3-11.4)  
       16 43 495,529 8.6 (6.4-11.7)  
       17 57 477,930 11.9  (9.2-15.5)  
Country     
       England 1,003 8,194,945 12.2 (11.5-13.0) 1 
       Scotland 139 1,286,924 10.8 (9.1-12.7) 0.88 (0.73-1.05) 
      Wales 69 649,399 10.6 (8.4-13.4) 0.87 (0.68-1.10) 
      Northern Ireland  36 377,106 9.5 (6.9-13.2) 0.77 (0.55-1.08) 
Calendar period 
   
 
1993-1997 50 603,213 8.3 (6.3-10.9) 1 
1998-2002 222 2,405,398 9.2 (8-1.10.5) 1.11 (0.82-1.51) 
2003-2007 404 3,572,886 11.3 (10.2-12.5) 1.36 (1.01-1.83) 
2008-2012 571 3,926,877 14.5 (13.4-15.8) 1.75 (1.31-2.34) 
Socioeconomic 
deprivation (Quintile 
of Townsend Index) 
   
 
1 (least deprived) 350 2,479,655 14.1 (12.7-15.7) 1.80 (1.45-2.22) 
2 295 2,032,782 14.5 (12.9-16.2) 1.85 (1.48-2.30) 
3 221 2,043,017 10.8 (9.5-12.3) 1.38 (1.09-1.73) 
4 198 1,901,385 10.4 (9.0-11.9) 1.33 (1.05-1.67) 
5 (most deprived) 110 1,402,742 7.8 (6.5-9.4) 1 
Missing 73 648,793 11.2 (8.9-14.1) 1.43 (1.06-1.92) 
  
    7 
 
Table 2. Incidence of Coeliac Disease Over Time by Sex and Age and Relative Incidence in 2008-2012 Compared to 1993-1997  
(N=2,063,421) 
Calendar period 
 Calendar year 1993-1997a 1998-2002a 2003-2007a 2008-2012a 
Unadjusted IRR for 
calendar periodb 
(95%CI) 
Sex 
     Male 7.8 (5.3-11.6) 7.7 (6.3-9.3) 9.3 (7.9-10.8) 10.9 (9.6-12.6) 1.39 (0.92-2.10) 
Female 8.8 (5.9-12.9) 10.9 (9.2-13.0) 13.5 (11.8-15.3) 18.3 (16.5-20.3) 2.09 (1.39-3.13) 
Age (years) 
     0-2 16.7 (11.5-24.1) 14.2 (11.1-18.0) 13.9 (11.3-17.3) 12.9 (10.4-15.8) 0.77 (0.50-1.18) 
3-9 5.7 (3.4-9.7) 8.7 (7.1-10.7) 12.1 (10.4-14.0) 16.4 (14.5-18.6) 2.85 (1.66-4.88) 
10-18 4.1 (2.1-8.8) 7.2 (5.6-9.2) 9.4 (7.9-11.1) 13.5 (11.8-15.4) 3.24 (1.60-6.56) 
Country      
     England 8.9 (6.7-11.9) 9.9 (8.6-11.4) 11.7 (10.5-13.0) 14.8 (13.5-16.2) 1.65 (1.22-2.24) 
     Scotland - 5.1 (3.0-8.7) 11.2 (8.5-14.8) 14.3 (11.3-17.9) 2.77 (1.56-4.90)c 
     Wales 11.0 (3.5-34.2) 9.2 (5.2-16.2) 10.3 (6.8-15.5) 11.5 (8.1-16.4) 1.04 (0.32-3.42) 
   Northern Ireland 5.9 (0.8-42.3) 6.3 (2.8-14.0) 5.3 (2.5-11.2) 16.4 (10.8-24.9) 2.76 (0.37-20.46) 
      
a Incidence rates of coeliac diseases per 100,000 person-years (95% CI). 
 
b Comparing the latest with the earliest calendar period, 
 
c Since there were no incident coeliac disease cases in the Scottish practices between 1993 and 1997, we used the period 1998-2002 as baseline  
IRR: Incidence Rate Ratio; CI confidence interval 
Interaction tests: sex and calendar year, LRT p value=0.4; age group and calendar year, LRT p value< 0.001; country and calendar year, LRT p value=0.05 
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Incident CD diagnoses across socioeconomic status  
We found a gradient across socioeconomic groups in CD diagnoses, with the highest CD incidence 
in children from the two least socioeconomically deprived areas, followed by a progressive 
reduction of CD incidence in the latter three quintiles (Table 1). The lowest incidence was in the 
most socioeconomically deprived areas. Tables 3 and 4 show, respectively, the absolute rate of CD 
and the adjusted IRRs for the association of CD with socioeconomic status, stratified by sex, age, 
calendar period and country. We observed a similar relationship between socioeconomic status and 
CD in both sexes, in all age groups, over time, and in all countries (all LRTs not statistically 
significant for interaction between these variables and socioeconomic status). There was a 
statistically significant socioeconomic gradient in each time period other than 1993-1997, when the 
highest incidence rate was observed in the third quintile.  Moreover, although we did not find a 
statistically significant socioeconomic trend in CD in smaller populations from Wales and Northern 
Ireland, they also had the highest incidence rate of CD in children from the least socioeconomically 
deprived areas and the lowest CD incidence rate in children from more socioeconomically deprived 
areas, in the 5th and 4th quintiles respectively (Figure 1).
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Table 3. Incidence of Coeliac Disease Across Socioeconomic Groups (N=2,063,421) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aIncidence rates of coeliac diseases per 100,000 person-years (95% confidence intervals). 
. 
 
 
 
Quintile of 
deprivation 1=Least deprived
a
 2a 3a 4a 5=Most depriveda Missing   
Sex  
      
Male 11.4 (9.7-13.4) 11.4 (9.5-13.6) 9.3 (7.7-11.4) 7.4 (5.9-9.3) 6.4 (4.8-8.5) 8.2 (5.6-11.9) 
Female 17.0 (14.8-19.6) 17.9 (15.4-20.7) 12.4 (10.4-14.8) 13.6 (11.4-16.2) 9.4 (7.3-12.0) 14.4 (10.8-19.2) 
Age (years) 
     
 
0-2 15.6 (12.3-19.8) 18.5 (14.5-23.5) 14.4 (11.0-18.8) 10.4 (7.5-14.3) 9.3 (6.3-13.8) 13.1 (8.3-20.5) 
3-9 14.6 (12.4-17.1) 15.7 (13.2-18.6) 9.9 (8.0-12.3) 11.9 (9.7-14.6) 8.3 (6.2-11.0) 11.9 (8.5-16.8) 
10-18 13.0 (10.9-15.4) 11.6 (9.5-14.2) 10.1 (8.1-12.5) 8.9 (7.0-11.3) 6.7 (4.9-9.2) 9.2 (6.0-14.2) 
Calendar period 
     
 
1993-1997 8.2 (4.5-14.9) 5.3 (2.4-11.9) 10.5 (5.9-18.5) 8.1 (4.2-15.6) 4.7 (1.7-12.6) 16.4 (8.2-32.8) 
1998-2002 12.3 (9.7-15.6) 10.0 (7.5-13.4) 8.6 (6.3-11.7) 8.2 (5.9-11.5) 5.2 (3.2-8.4) 8.2 (4.7-14.5) 
2003-2007 12.6 (10.4-15.2) 14.8 (12.2-17.9) 11.4 (9.1-14.2) 9.3 (7.2-12.0) 7.6 (5.5-10.6) 8.5 (5.4-13.5) 
2008-2012 17.4 (14.9-20.4) 18.4 (15.5-21.7) 11.7 (9.5-14.3) 13.0 (10.6-16.0) 10.2 (7.8-13.3) 14.4 (10.3-20.0) 
Country 
      
England 14.2 (12.7-15.9) 14.7 (12.9-16.7) 11.1 (9.6-12.8) 10.9 (9.3-12.7) 8.0 (6.4-9.9) 11.9 (9.2-15.4) 
Scotland 12.6 (8.2-19.1) 17.0 (12.7-22.7) 9.6 (6.4-14.5) 8.2 (5.4-12.6) 7.1 (4.5-11.3) 9.2 (4.8-17.8) 
Wales 14.4 (9.2-22.6) 10.2 (6.0-17.3) 9.1 (5.3-15.6) 11.4 (6.9-18.5) 7.2 (3.2-16.0) 7.3 (1.0-51.9) 
Northern Ireland 13.1 (6.2-24.2) 7.8 (3.2-18.8) 11.3 (5.7-22.7) 4.1 (1.0-14.4) 9.1 (4.1-20.4) 9.6 (4.0-23.1) 
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aIncidence rate ratio compared to most deprived (5th quintile) 
Adjusted for: bage and calendar period and country, csex and calendar period and country, dsex and age and country, esex and calendar period and age. 
d Excluding missing data 
Interaction tests: sex and socioeconomic status, LRT p value=0.67; age group and socioeconomic status, LRT p value 0.78; calendar years and socioeconomic status, LRT p 
value=0.42; countries and socioeconomic status, LRT p value=0.87 
 
 
 
Table 4. Adjusted Incidence Rate Ratios for the Association of Coeliac Disease with Socioeconomic Status, Stratified by Sex, Age,  Calendar Period and Country 
(N=2,063,421 ) 
Quintile of 
deprivation 1=Least deprived
a
 2a 3a 4a 5=Most deprived p value for trendd 
 
Missinga 
Sexb         
 
  
Male  1.76 (1.26-2.46) 1.78 (1.26-2.50) 1.45 (1.02-2.06) 1.15 (0.79-1.66) 1 <0.001 1.26 (0.78-2.03) 
Female 1.79 (1.35-2.37) 1.89 (1.42-2.52) 1.30 (0.96-1.77) 1.44 (1.06-1.94) 1 <0.001 1.51 (1.03-2.20) 
Age (years)c 
     
  
0-2 1.57 (0.99-2.48) 1.92 (1.21-3.04) 1.48 (0.92-2.38) 1.08 (0.65-1.79) 1 0.004 1.38 (0.76-2.51) 
3-9 1.70 (1.22-2.36) 1.86 (1.33-2.59) 1.17 (0.82-1.67) 1.41 (0.99-2.01) 1 <0.001 1.43 (0.91-2.23) 
10-18 1.97 (1.37-2.83) 1.74 (1.19-2.53) 1.52 (1.03-2.23) 1.35 (0.90-2.00) 1 <0.001 1.39 (0.82-2.37) 
Calendar periodd 
     
  
1993-1997 1.47 (0.49-4.63) 1.00 (0.28-3.56) 1.98 (0.63-6.15) 1.58 (0.49-5.14) 1 0.95 3.14 (0.94-10.50) 
1998-2002 2.22 (1.31-3.79) 1.87 (1.10-3.25) 1.59 (0.90-2.81) 1.55 (0.87-2.76) 1 <0.001 1.54 (0.73-3.24) 
2003-2007 1.63 (1.11-2.38) 1.92 (1.31-2.81)   1.48 (1.00-2.20) 1.21 (0.81-1.83) 1 <0.001 1.11 (0.63-1.97) 
2008-2012 1.71 (1.25-2.34) 1.81 (1.31-2.48) 1.15 (0.81-1.61) 1.28 (0.92-1.80) 1 <0.001 1.39 (0.91-2.13) 
Countrye 
    
 
  
England    1.79 (1.04-2.3) 1.86 (1.44-2.39) 1.39 (1.07-1.82) 1.37 (1.04-1.79) 1 <0.001 1.47 (1.05-2.06) 
Scotland 1.66 (0.89-3.10) 2.23 (1.29-3.86) 1.26 (0.68-2.34) 1.11 (0.59-2.08) 1 0.004 1.21 (0.54-2.71) 
Wales 2.02 (0.81-5.07) 1.43 (0.55-3.73) 1.26 (0.48-3.34) 1.58 (0.62-4.05) 1 0.188 0.95 (0.11-7.91) 
Northern Ireland 1.45 (0.53-4.00) 0.85 (0.26-2.80) 1.20 (0.41-3.46) 0.44 (0.08-2.20) 1 0.340 1.21 (0.36-4.06) 
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Sensitivity analyses  
There were 230 children diagnosed with CD after 2 years of age with a first CD record or gluten-
free prescription within six months of GP registration (18.4% potentially prevalent cases out of the 
total 1,247 case population). After excluding these potentially prevalent cases, the overall incidence 
was 9.7 per 100,000 person years. Variations between subgroups, however, remained similar to the 
main analyses (Supplementary 1). After restricting our CD cases to children with a gluten-free 
product prescription, there were 1,007 (80.8% of the total 1,247 case population), resulting in an 
incidence of 9.6 per 100,000 person-years. Again, IRRs remained similar to main analyses, showing 
the same incidence patterns by sex, age, calendar time, country and socioeconomic status 
(Supplementary 2).
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DISCUSSION 
Main findings 
The overall CD incidence of 11.9 per 100,000 person-years was similar across the UK countries and 
higher in girls than in boys. Whilst CD incidence up to age 2 remained stable over time, diagnoses 
in older children have almost tripled over the past 20 years. We found a strong socioeconomic 
gradient in CD diagnoses such that children living in less socioeconomically deprived areas were 
about twice as likely to be diagnosed as those in more deprived areas. This pattern held for boys and 
girls and for all ages. Across all 4 countries we found evidence of a similar socioeconomic gradient 
in CD diagnosis.    
 
Strengths and limitations 
This is the largest study of childhood CD in which the possible role of socio-demographic aspects 
on the rate of CD diagnosis has been examined. The demographics of our study population are 
comparable to those of children in the UK population,[27] so our findings are likely to be 
representative of this population. We considered CD diagnosis by XVLQJDSK\VLFLDQ¶VUHSRUWDV
recorded in GP as we did not have comprehensive information on serological or histological testing 
for each patient. Whilst our pragmatic approach may have resulted in false-positive cases, the 
accuracy of CD recording in primary care was specifically validated against medical records [28] in 
a small sample of patients, showing a good concordance between paper and electronic records. We 
used a single diagnostic code to maximise the sensitivity in the main analysis but when we used a 
more specific case definition (including only children with at least one CD code and at least one 
prescription for gluten-free product), the incidence patterns across age, sex, calendar year and 
socioeconomic status remained very similar to our main analyses. We found that 80.8% of children 
with CD had a prescription for a gluten-free product which was similar to the finding reported by 
Hall et al.[29] They conducted a questionnaire study of a sample of CD patients identified by Read 
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codes in north east England and whilst they confirmed that all patients did have CD disease, only 
86.1% of their CD patients obtained a gluten-free prescription. We believe therefore that it is 
unlikely that there has been any great amount of over ascertainment of CD in our study.   
Moving on from our outcome to consider our principle exposure measurement, the Townsend Index 
is a validated measure of how socioeconomically deprived an area is within the UK based on 
standardised indicators.  However, this score gives an overall deprivation index of the people living 
in a particular area of approximately 50 households, not taking into account individual variation in 
deprivation levels or the differences between urban and rural areas. The small number of CD cases 
registered in Wales and Northern Ireland reduced the statistical power for these particular analyses. 
The relationship between CD diagnosis and socio-economic grouping did not hold in the time 
period 1993-1997 which could be related to the differences in diagnosis tools and clinical 
presentation during that period compared to the following ones. Diagnostic biopsies at that time 
were frequently carried out by general paediatricians using Crosby or Watson capsules, rather than 
requiring referral to a paediatric gastroenterologist for endoscopic biopsy.  Furthermore, only in the 
most recent decades there has been a shift towards older average age at diagnosis among children  
and altered clinical presentation [30] (i.e. less distension, failure to thrive and more subtle 
symptomatology). [31] It is possible that these issues could have contributed to the different 
diagnosis rates among socioeconomic groups that we have observed. An alternative perspective is 
that the apparently older age at diagnosis observed in various studies has been driven by greater 
ascertainment and therefore earlier (younger) diagnosis of older (>10 years of age) children. 
Finally, we cannot exclude that the lack of a gradient seen in the period 1993-1997 was simply 
related to the lack of adequate sample size during these years. 
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Comparison with previous literature 
Socioeconomic status has been proposed as a possible factor in the development of CD, although 
existing studies show contradictory results. As Table 5 shows, these studies have several differences 
in study design, outcome, exposure definition, study population and setting. Most of them were 
conducted using groups of already-diagnosed CD patients, [12-19] and the only two population-
based studies consider patients detected by serological screening rather than clinical diagnosis. [20, 
21] Three studies have been conducted in different areas of the UK on children.[14, 15, 18] Whyte 
et al. [14] reported a higher risk of CD diagnosis in children, aged less than 16 years, belonging to 
the least deprived areas compared to those from the most deprived areas in South Wales, which is 
similar to our results. This cross-sectional study used The Welsh Index of Multiple Deprivation as 
measure of the socioeconomic status which is comparable to the Townsend Index. Conversely, a 
small Scottish cohort study [15] found no large difference between the Standard Index of Multiple 
Deprivation and urban/rural indices in children with CD and the general population in Scotland.  In 
2009, Robert et al. [18] reported that in an area of the South of England children from manual social 
classes IV and V had a 4-fold increased risk of CD compared to those from professional social 
classes I and II. Finally, looking at all ages in the UK population, our recent population-based study, 
using the Clinical Practice Research Database,[13] also described that CD occurred more 
commonly in areas with the least socioeconomic deprivation. Outside the UK, three Swedish 
studies [16, 17, 19] have reported contradictory results on the association between socioeconomic 
status and CD (Table 5). Similarly to our results, Burger et al [12] have recently described, using 
registered pathology reports in the Netherlands, that patients diagnosed in childhood were more 
often from higher socioeconomic status compared to patients diagnosed later in life. 
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Table 5. Previous Literature on the Association between Socioeconomic Status and Coeliac Disease 
 Geographic 
area  
Study population Source of the outcome 
N=number of cases 
Source of socioeconomic status Main findings 
Diagnosed CD (serology and/or biopsy positive cases) within medical settings 
Burger JPW 
2014 [12] 
Netherlands Subjects identified into the  Dutch 
Pathology Registry  which covers 
all pathology labs in Netherlands 
1995-2010 
N= 6,444 
 
CD diagnosis according to 
biopsy reports  
N=4,014 
The socioeconomic status scores 
based on income, level of education 
and employment 
Patients diagnosed with CD 
during childhood were more 
often from an area with a higher 
socioeconomic status compared 
to patients diagnosed later in life 
(p <0.001).  
 
West J 
2014 [13] 
United 
Kingdom  
All ages UK population registered 
with the  Clinical Practice Research 
Datalink-1990-2011 
N= 65,856,848 person-years 
People with Read codes 
representing CD (J690.00; 
J690.13; J690z00; J690100; 
J690.14; J690000) 
N=9,087 
 
Indices of Multiple Deprivation The CD incidence was 27% 
lower in people from the most 
deprived areas than in people 
from the least deprived ones 
(IRR 0.83, 95% CI 0.77- 0.89). 
Whyte LA 
2013 [14] 
Cardiff, 
Newport and 
Powys 
(South 
Wales) 
The total paediatric 
Population (age <16) in South 
Wales (UK national census 2008). 
 N=298,530 children 
CD diagnosis  according to 
EPSGHAN 1990 criteria 
in the same tertiary medical 
centre between 1995 and 2012. 
N=232 
 
Welsh Index of Multiple 
Deprivation  
The prevalence of 
CD in the lowest deprivation 
level was 1.16/1000 and 
0.49/1000 in the highest 
deprivation  level  
White LE  
2013 [15] 
Southeast 
Scotland 
The total paediatric 
Population (age <16) in Southeast 
Scotland- 1990-2009 (Scotland 
census) 
N= ׽225,000 children 
 
CD diagnosis according to 
EPSGHAN 1990 criteria. Data 
from: hospital records (ICD-
codes of CD), paediatric 
pathology records, regional 
clinical database, regional 
serology database, and the 
electronic hospital record. 
N=266 
 
The Scottish government data for 
the Standard Index of Multiple 
Deprivation and urban/rural indices 
The median of the Standard 
Index of Multiple Deprivation 
score and urban-rural 
classification indices of patients 
with CD were comparable to the 
general  population of 
southeastern Scotland  
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Olén O 
2012 [16] 
Sweden Individuals aged 16-64 years using 
the Total Population Register 
1969-2008 
N= 174,186 subjects 
CD diagnosis according to 
biopsy reports collected from 
all Swedish pathology 
departments 
N=29,096 
  
European Socioeconomic 
Classification based on occupation. 
Data collected using The Swedish 
Occupational Register 
Individuals from the lowest 
social class were 11% less likely 
to be diagnosed with CD  
(OR 0.89, 95% CI 0.84±0.94). 
Wingren CJ  
2012 [17] 
Sweden Prospective evaluation of babies 
born in Sweden between 1987 and 
1993 (follow-up 2 years) 
N=392,568 males and 372,112 
females. 
The Swedish National Hospital 
Discharge Registry according 
to ICD codes of CD 
N=845 in males and 1,401 in 
females. 
,QIRUPDWLRQRQWKHPRWKHUV¶ 
pre-tax equalized household 
income and social allowance 
for the year before delivery (5 
classes). 
Boys born to mothers in an overt 
low socioeconomic position had 
a higher risk of CD (OR 1.37 
(95% CI 1.03±1.82) than those 
with mother with high income 
and no social allowance. 
 
Robert S 
2009 [18] 
South East 
England 
Babies born in the south east of 
England between 1970 and 1999 
(mean follow-up duration 18 years) 
using the Oxford record linkage 
study database having linked 
maternity data in the same dataset 
N= 248, 521 
 
Children with both a maternity 
record and a subsequent 
admission for CD (ICD codes 
of CD) in the Oxford record 
linkage study database 
N=90 
Information collected from 
maternal records in the Oxford 
record linkage study database  
Children from manual social 
classes IV and V had a 4.02 
increased risk of coeliac disease 
(95% CI = 1.96±8.25), compared 
to those from professional social 
classes I and II. 
Ludvigsson J 
2005 [19] 
Sweden Babies born in southeast Sweden  
between 1997 and 1999 (follow-up 
15 years) 
N= 15,875 single births 
Coeliac cases reported by eight 
paediatric departments. 
A case was included if he had  
intestinal biopsy suggesting 
CD, no symptoms after the 
introduction of a gluten-free 
diet and/or no or only minor 
histopathological abnormalities 
consistent with CD at the 
control biopsy under treatment 
with gluten-free diet  
N=45 
Information collected in 
questionnaire completed by the 
mothers shortly after childbirth on: 
place of living 1 year before 
conception, maternal employed 
during pregnancy, paternal 
employed the year before the 
conception, family crowed living 
CD was less common in mother 
who had worked less than 3 
months during pregnancy 
(OR=0.29; 95% CI: 0.09±0.94; 
p=0.039). The other 
socioeconomic factors were not 
associated. 
Screening detected CD in the general population 
Kondrashova 
A  2008 [20] 
Finland 
and Russia 
Schoolchildren  
Russia Karelia: age ranged 6.2-18.3 
years (1997-2001) 
N= 1,988 children 
 
Northern Finland: age ranged 7-18 
years (1994) 
Serological screening 
by tTGA 
All subjects who were 
positive were offered an 
intestinal biopsy to confirm 
CD diagnosis. 
N=4 in Russia and 34 in 
Comparison between two areas 
with opposite socioeconomic 
condition (poor Russia vs rich 
Finland). 
0.6% of the children (12/1988; 
CI 0.3%±1.1%) in Russian 
Karelia tested positive for tTGA 
compared to 1.4% (52/3654; CI 
1.1%±1.9%) in the Finnish 
cohort. Biopsy-proven CD:  N=4 
in Russia and 34 in Finland (no 
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ESPGHAN= European Society of Paediatric Gastroenterology, Hepatology and Nutrition, CD= coeliac disease, IRR=incident rate ratio, OR = Odds ratio, CI=confidence 
interval, ICD=international classification of disease, tTGA= IgA antitransglutaminase, EMA= antiendomisial antibody 
N= 3,654 children Finland   biopsy in 13 subjects). 
West J 
2003 [21] 
Cambridge Participants, age 45-76 years 
registered with a general practices in 
Cambridge, England (1990-1995) 
N=7,550 
Serological screening by 
EMA 
N=87 
Participant-reported occupation 
categorised as professional, skilled, 
unskilled/partly skilled.  
EMA positivity less common in 
partly skilled or unskilled 
workers, as compared to 
professionals (OR 0.51 95% CI 
0.18±1.43). 
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Interpretation 
It is not possible from this study nor from previous literature to conclusively explain the reasons for 
this gradient, which may indicate either that the ascertainment of disease varies among social 
classes or that there is a true variation in incidence by socioeconomic status. For example, 
individuals from more deprived areas may be less likely to seek medical care or consultation in 
general and thus be potentially less likely to be tested for CD.[10, 32, 33] Aside from ascertainment, 
however, it is also possible that people of different socioeconomic groups are exposed to different 
risk factors, which might indirectly contribute to CD development. Two studies of screening-
detected CD (Table 5), one in the UK showing a weak socioeconomic gradient [21] and the other 
reporting a higher prevalence of detected CD in children from Finland than in those from a more 
socioeconomically deprived Russian area,[20] may support this conjecture. The duration of 
exclusive breastfeeding and the optimal timing of gluten introduction for infants in terms of their 
contribution to the risk of developing CD have been debated for several years. Previous studies 
have implied a window of time (4-6 months of age) during which the introduction of gluten might 
facilitate induction of tolerance (window of tolerance) [34-38], however, evidence from two newly 
published clinical trials has not confirmed this [39, 40]. Vriezinga et al recruited HLA-DQ2 or 
HLADQ8 positive newborns with a first degree relative affected by CD from 8 countries and 
showed no difference on the risk of CD by 3 years of age between infants randomised to 100 mg of 
immunologically active gluten daily (combined with lactose) and those given a placebo (lactose 
only) between 4 and 6 months [39].  Furthermore, they observed no association of breastfeeding 
duration, regardless of whether it was exclusive or with gluten introduction, on CD development. 
Lionetti et al [40] conducted a trial in Italy of predisposed newborns (those with a first degree 
relative with CD) and found that the introduction of gluten at 12 months versus 6 months slightly 
delayed the onset of CD, but CD prevalence was no different by 5 years of age. In addition, the 
authors did not detect any effect of breastfeeding on the development of CD. These trials do not 
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support the possibility that differences in time of gluten introduction or breastfeeding duration 
explain the socioeconomic gradient we observed in our population. Furthermore, an analysis of 
breastfeeding in England showed a lower prevalence of exclusive breastfeeding at 6-8 weeks post-
delivery among women from the most deprived areas than in the least deprived areas [41]. Since the 
higher incidence of CD in children from less deprived groups that we observed is opposite to the 
relationship this would be expected to cause; this is further evidence that known differences in 
breastfeeding are unlikely to explain the socioeconomic gradient of CD. 
Another potential explanation of the observed socioeconomic gradient could be related to the so 
called hygiene hypothesis.[42] This hypothesizes that a decreased antigenic exposure in childhood 
in less deprived groups causes an immunological over-reaction at the time of a subsequent antigenic 
contact, [42, 43] i.e. gluten in the case of CD.  A greater exposure to childhood infection may also 
occur in children of lower socioeconomic groups [44] which could eventually protect them from 
later development of CD via this mechanism. This explanation, however, is inconsistent with 
previous evidence of early infections as potential risk factor for CD.[45, 46] Lastly, little is known 
about dietary variation in gluten according to socioeconomic group [47] so we cannot speculate 
whether this may play a role.[48]  
 
CONCLUSION 
Based on the current evidence, the most plausible explanation for the socioeconomic gradient in the 
incidence of childhood CD whereby children from least deprived areas have CD diagnosed more 
often than those from the most deprived areas, is that ascertainment of disease varies rather than the 
true occurrence of CD. Awareness campaigns and the implementation of diagnostic guidelines may 
help to implement strategies for case-finding in all children and reduce this inequality. Moreover, a 
greater use of the new paediatric guidelines [49, 50] with the possibility to diagnose symptomatic 
cases without biopsy might increase the access to diagnosis in children from the most deprived 
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areas.  Future studies might continue to explore the possible association between exposures to 
different specific risk factors with the occurrence of CD across socioeconomic groups.
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Figure 1. Coeliac disease incidence across countries of the UK according to 
socioeconomic group 
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What is known on this Subject: Existing studies on the socio-demographic distribution of 
childhood clinically diagnosed coeliac disease are in small study populations and findings are 
contradictory. 
 
What This Study Adds: Children from the most socioeconomically deprived areas are only half as 
likely to be diagnosed with coeliac disease as those from less deprived areas.  
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